國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Radiopharmaceuticals for therapy

Dash, Ashutosh.

Radiopharmaceuticals for therapy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Radiopharmaceuticals for therapyby F. F. (Russ) Knapp, Ashutosh Dash.
作者:	Knapp, F. F. (Russ)
其他作者:	Dash, Ashutosh.
出版者:	New Delhi :Springer India :2016.
面頁冊數:	xxiv, 347 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Radiopharmaceuticals.
電子資源:	http://dx.doi.org/10.1007/978-81-322-2607-9
ISBN:	9788132226079$q(electronic bk.)

Radiopharmaceuticals for therapy
Knapp, F. F. (Russ)

Radiopharmaceuticals for therapy[electronic resource] /by F. F. (Russ) Knapp, Ashutosh Dash. - New Delhi :Springer India :2016. - xxiv, 347 p. :ill., digital ;24 cm.

This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT) Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.

ISBN: 9788132226079$q(electronic bk.)

Standard No.: 10.1007/978-81-322-2607-9doiSubjects--Topical Terms:

347769
Radiopharmaceuticals.

LC Class. No.: RS431.R34

Dewey Class. No.: 615.842

Radiopharmaceuticals for therapy
LDR:02382nmm a2200301 a 4500 001 483077
003 DE-He213
005 20160817155819.0
006 m d
007 cr nn 008maaau
008 161007s2016 ii s 0 eng d
020 $a 9788132226079$q(electronic bk.)
020 $a 9788132226062$q(paper)
024 7 $a 10.1007/978-81-322-2607-9 $2 doi
035 $a 978-81-322-2607-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.R34
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
082 0 4 $a 615.842 $2 23
090 $a RS431.R34 $b K67 2016
100 1 $a Knapp, F. F. (Russ) $3 740432
245 1 0 $a Radiopharmaceuticals for therapy $h [electronic resource] / $c by F. F. (Russ) Knapp, Ashutosh Dash.
260 $a New Delhi : $b Springer India : $b Imprint: Springer, $c 2016.
300 $a xxiv, 347 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT) Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
650 0 $a Radiopharmaceuticals. $3 347769
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Nuclear Medicine. $3 275838
650 2 4 $a Pharmacotherapy. $3 615025
650 2 4 $a Oncology. $3 195181
650 2 4 $a Endocrinology. $3 196517
700 1 $a Dash, Ashutosh. $3 740433
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-81-322-2607-9
950 $a Medicine (Springer-11650)